Together, tau pathology and neuroinflammation synergistically drive neurodegeneration and clinical symptoms in tauopathies such as PSP, CBD, FTDP-17, PiD, AGD and CTE. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.